Efficacy of recombinant human epidermal growth factor plus sodium hyaluronate eye drops in diabetic dry eye post-cataract surgery

Figure 1 Comparison of pre- and posttreatment dry eye scores between the recombinant human epidermal growth factor + sodium hyaluronate eye drops group and sodium hyaluronate eye drops alone group. ^aP < 0.05.

Figure 2 Comparison of pre- and posttreatment tear film breakup time, Schirmer I test, and fluorescein staining scores between the recombinant human epidermal growth factor + sodium hyaluronate eye drops group and sodium hyaluronate eye drops alone group. A: Comparison of tear film breakup time results; B: Comparison of Schirmer I test results; C: Comparison of fluorescein staining scores. ^aP < 0.05. Sit: Schirmer I test; FL: Fluorescein staining; BUT: Breakup time.

Figure 3 Pre- and posttreatment tear inflammatory markers between the recombinant human epidermal growth factor + sodium hyaluronate eye drops group and the sodium hyaluronate eye drops alone group. A: Comparison of interleukin-6 levels; B: Comparison of tumor necrosis factor-α levels. ^aP < 0.05. TNF-α: Tumor necrosis factor-α; IL-6: Interleukin-6.